ReviewFrontiers in pharmacology2024

Hypoxia-inducible factor-prolyl hydroxylase inhibitors for treatment of anemia in chronic kidney disease: a systematic review and network meta-analysis.

Song Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.